Stay updated on CC-99712 ADC in Relapsed/Refractory Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the CC-99712 ADC in Relapsed/Refractory Multiple Myeloma Clinical Trial page.

Latest updates to the CC-99712 ADC in Relapsed/Refractory Multiple Myeloma Clinical Trial page
- Check4 days agoChange DetectedThe ClinicalTrials.gov site footer now identifies the platform as revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check11 days agoChange DetectedA banner announces that NIH is transitioning to using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI), with updates and FAQs available.SummaryDifference0.5%

- Check18 days agoChange DetectedThe site footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check25 days agoChange DetectedThe site revision label changed from v3.7.0 to v3.7.1; the study record content remains unchanged.SummaryDifference0.1%

- Check46 days agoChange DetectedRecord History now includes a new entry for Revision: v3.7.0 and removes the previous Revision: v3.6.6 entry. This represents a behind-the-scenes version update to the page rather than a change to study data or user-facing content.SummaryDifference0.1%

- Check67 days agoChange DetectedA new Revision: v3.6.6 entry was added to the history, replacing Revision: v3.6.5; this reflects a small update to the page's version history rather than substantive content changes.SummaryDifference0.1%

Stay in the know with updates to CC-99712 ADC in Relapsed/Refractory Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CC-99712 ADC in Relapsed/Refractory Multiple Myeloma Clinical Trial page.